CDK1 and colorectal cancer: For example, in pancreatic ductal adenocarcinoma, overexpression of CDK1 indicates poor prognosis [34], and CCNA2 is considered a possible biomarker for progression (eg, growth and apoptosis) of colorectal cancer [35].